Christine Lynn Bentley

Title: Christine Lynn Bentley: Innovator in Vaginal Pharmaceutical Compositions

Introduction

Christine Lynn Bentley is a notable inventor based in Caledonia, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of vaginal pharmaceutical compositions. Her innovative work addresses important health issues and showcases her expertise in pharmaceutical sciences.

Latest Patents

Christine Lynn Bentley holds 1 patent for her invention titled "Vaginal pharmaceutical compositions and methods for preparing them." This patent describes compositions that contain an active pharmaceutical ingredient selected from antimicrobial imidazoles and a polysaccharide. The pH of these compositions is carefully formulated to be greater than 4.25 and less than about 8. In preferred formulations, the active ingredient includes metronidazole, while the polysaccharide is hypromellose. These compositions are designed for application to vaginal tissue to treat various diseases, such as bacterial vaginosis, or for prophylactic purposes.

Career Highlights

Christine is currently associated with Teva Pharmaceuticals USA, Inc., where she continues to advance her research and development efforts. Her work at Teva Pharmaceuticals reflects her commitment to improving women's health through innovative pharmaceutical solutions.

Collaborations

Christine Lynn Bentley collaborates with her coworker, Karen Feldtmose, who is also a woman. Their partnership exemplifies the importance of teamwork in the field of pharmaceutical innovation.

Conclusion

Christine Lynn Bentley's contributions to vaginal pharmaceutical compositions highlight her role as an innovator in the pharmaceutical industry. Her work not only addresses critical health concerns but also demonstrates the impact of dedicated research and collaboration in advancing medical science.